Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors

2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors

US Patent 9675606 · Granted Jun 13, 2017

Estimated economic value: $15,470,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders2025
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders2023
Modified lipidated relaxin B chain peptides and their therapeutic use2023
Phosphonium-ion tethered tetracycline drugs for treatment of cancer2021
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders2021
Triphenylphosphonium-tethered tetracyclines for use in treating cancer2021
Modified lipidated Relaxin B chain peptides and their therapeutic use2021
Modified relaxin B chain peptides and their therapeutic use2021
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2021
Modified lipidated Relaxin B chain peptides and their therapeutic use2021
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2020
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019